Navigation Links
Global Markets and Manufacturing Technologies for Protein Drugs -- Focus on Cytokines and Monoclonal Antibodies
Date:9/30/2014

LONDON, Sept. 30, 2014 /PRNewswire/ -- STUDY OBJECTIVES

The objective of BCC in conducting this study is to provide an overview of the current and future characteristics of the global market for protein drugs/therapeutics. The key objective is to present a comprehensive analysis and future direction of protein drugs as an important tool in the treatment of various diseases.

This report explores present and future strategies within the protein therapeutics market, which includes peptide hormones, therapeutic enzymes, cytokines, monoclonal antibodies, blood factors, vaccines and peptide antibodies. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The classifications, manufacturing processes and usage of protein drugs are also portrayed.

A detailed analysis of protein therapeutics industry structure has been conducted. Revenues are broken down by region, by type and by manufacturing method. Sales figures are given for 2011, 2012 and estimated for the five-year period from 2013 through 2018.
The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

Widespread research in the field of protein therapeutics has discovered specific functionality that provides therapeutic treatments for various diseases.

R&D spending, along with increasing competition, patent expiries and new technologies are providing a new direction. New advancements, new product launches and a changing lifestyle have caused the market to grow in the foreseeable future. This study looks at almost all the systems affected by these factors.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type of technology in light of the new technologies, growing competition, and changing customer needs.

INTENDED AUDIENCE

This study contributes to the areas of market growth in protein therapeutics manufacturers and users. Pharmaceutical biotechnical companies, research institutes, and physicians will find this study to be of interest.

SCOPE OF THE STUDY

The scope of this study encompasses protein therapeutics in pharmaceutical and biotechnology markets. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections, and market shares. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes countries like India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, etc.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of enzyme inhibitors and technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies were surveyed to obtain data for this study. Included were manufacturers and end users of kinase inhibitors in therapeutic categories and various disease sectors industries. Data were gathered from various industry sources. BCC Research spoke with officials within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

ABOUT THE AUTHOR

A team of professionals in the biotechnology industry carried out this study. The project manager is Shalini S Dewan, who holds a master's degree in pharmaceutical chemistry and has over 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC Research are:

• Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems.
• Orthopedic Drugs, Implants and Devices.
• Imaging Reagents; Regulatory Industry.
• Dynamic Sera, Media and Reagents Used in Biotechnology.
• Contract Pharmaceutical Manufacturing, Research and Packaging.
• Chiral Technology: Global Markets.
• Autacoids and Related Drugs.
• Contraceptives.
• Liver Disease Treatments.
• The Global Market, Hormone Replacement Therapies and Other Hormone Therapies.
• Global Markets, Cardiovascular Medicine: Diagnostics, Drugs and Devices.
• Cancer Therapies: Technologies and Global Market;
• Medical Imaging Reagents and Analysis Equipment.

The lead consultant for this project was Dr. Kapil A Setia, who holds a doctoral degree in life sciences. He has a number of research publications to his credit, including his thesis, which was given an award of excellence.

REPORT HIGHLIGHTS

This report will provide:
• An overview of the markets for major classes of protein with a focus on cytokines and monoclonal antibodies
• Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
• Examinations of current successes, including size and sales forecasts for this segment over the next five years
• Discussion of the regulatory environment, technological developments and their related strengths and weaknesses, as well as discussion on growing competition and changing customer needs.

Download the full report: https://www.reportbuyer.com/product/1863179/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

 

 


'/>"/>
SOURCE ReportBuyer
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research
2. MediciGlobals Alzheimers Community Reaches 200,000 likes and more than half a million weekly visitors
3. Global Medical Manufacturers Turn to Distributors to Tap the Eastern European Market
4. CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer
5. Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research
6. Global Cardiac Pacemakers - Trends, Estimates and Forecasts to 2018
7. Lillys seventh Global Day of Service rallies 24,000 employees in nearly 60 countries
8. Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020: Transparency Market Research
9. Consistent Innovation Secures Future of Global Medical Battery Market, Finds Frost & Sullivan
10. Global Mask Industry Report 2014
11. Global Sterilization Equipment Industry Report 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2020)... ... April 02, 2020 , ... ... has won SignatureCare Emergency Center's 2020 Spring Semester Scholarship. , The ... the medical and healthcare field, is aimed at helping the students pay tuition ...
(Date:4/1/2020)... ... 01, 2020 , ... As the coronavirus pandemic spreads, ... accessible primary care, launches its telemedicine platform, AFC/TeleCare, as a solution in this ... virtual visits, allowing our medical providers to easily connect with patients for all ...
(Date:3/30/2020)... (PRWEB) , ... March 30, 2020 , ... ... with its employees, today announced it has launched a series of survey question ... and gather actionable feedback to inform mission-critical decisions. As the current situation continues ...
Breaking Medicine Technology:
(Date:3/30/2020)... ... March 30, 2020 , ... Frontline Public Safety Solutions is ... an effort to keep frontline officers and the public safe in the face ... while minimizing direct contact. They are also freeing up 911 lines for genuine ...
(Date:3/28/2020)... ... 2020 , ... With social distancing, or more accurately physical ... people of all ages are challenged to find different ways to connect socially. ... best of times—the physical distance mandated to prevent the pandemic’s spread can be ...
(Date:3/28/2020)... MYRTLE BEACH, S.C. (PRWEB) , ... March 27, ... ... regionally renowned orthopedic practice OrthoSC is now offering telemedicine as an ... visit with one of the practice’s doctors in the comfort of their own ...
(Date:3/28/2020)... CINCINNATI (PRWEB) , ... March 28, 2020 , ... ... revenue cycle management services, integrated practice management, and patient engagement solutions has expanded ... coronavirus outbreak. , In this time of crisis, telemedicine has a big ...
(Date:3/27/2020)... ... 27, 2020 , ... Justin P. Kubeck, MD of Ocean ... has been approved every year consecutively since 2016. Dr. Kubeck is board certified ... , Dr. Kubeck’s medical education began at Thomas Jefferson University. He then completed ...
Breaking Medicine News(10 mins):